Eric Bjerkholt - Net Worth and Insider Trading

Eric Bjerkholt Net Worth

The estimated net worth of Eric Bjerkholt is at least $8 Million dollars as of 2026-09-12. Eric Bjerkholt is the CHIEF FINANCIAL OFFICER of Mirum Pharmaceuticals Inc and owns about 36,355 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $4 Million. Eric Bjerkholt is the CFO of Chinook Therapeutics Inc and owns about 38,867 shares of Chinook Therapeutics Inc (KDNY) stock worth over $2 Million. Eric Bjerkholt is also the CFO of Aimmune Therapeutics Inc and owns about 42,967 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $1 Million. Besides these, Eric Bjerkholt also holds Cerus Corp (CERS) , Corium International Inc (CORI) , Sunesis Pharmaceuticals Inc (SNSS) , CalciMedica Inc (CALC) . Details can be seen in Eric Bjerkholt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Bjerkholt has not made any transactions after 2026-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Eric Bjerkholt

Are these stocks worth buying? — GuruFocus analysis for each holding

- GF

MIRM Mirum Pharmaceuticals Inc

47% of holdings · $3.6M

KDNY Chinook Therapeutics Inc

21% of holdings · $1.6M

AIMT Aimmune Therapeutics Inc

20% of holdings · $1.5M

9% of holdings · $652K

CORI Corium International Inc

4% of holdings · $311K

SNSS Sunesis Pharmaceuticals Inc

Eric Bjerkholt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Bjerkholt owns 11 companies in total, including Aimmune Therapeutics Inc (AIMT) , Cerus Corp (CERS) , and CalciMedica Inc (CALC) among others .

Click here to see the complete history of Eric Bjerkholt’s form 4 insider trades.

Insider Ownership Summary of Eric Bjerkholt

Ticker	Company	Transaction Date	Type of Owner
AIMT	Aimmune Therapeutics Inc	2020-10-10	Chief Financial Officer
CERS	Cerus Corp	2026-06-09	director
CALC	CalciMedica Inc	2023-05-31	director
		2018-11-27	director
		2016-11-30	EVP & CFO & Corp. Secretary
		2004-03-01	director
		2005-09-27	Senior VP & CFO
		2023-02-10	Chief Financial Officer
		2023-04-05	director
		2026-08-11	CHIEF FINANCIAL OFFICER
		2025-01-27	director

Eric Bjerkholt Latest Holdings Summary

Eric Bjerkholt currently owns a total of 7 stocks. Among these stocks, Eric Bjerkholt owns 36,355 shares of Mirum Pharmaceuticals Inc (MIRM) as of August 11, 2026, with a value of $4 Million and a weighting of 47.05%. Eric Bjerkholt owns 38,867 shares of Chinook Therapeutics Inc (KDNY) as of February 10, 2023, with a value of $2 Million and a weighting of 20.68%. Eric Bjerkholt also owns 42,967 shares of Aimmune Therapeutics Inc (AIMT) as of March 12, 2020, with a value of $1 Million and a weighting of 19.53%. The other 4 stocks Cerus Corp (CERS) , Corium International Inc (CORI) , Sunesis Pharmaceuticals Inc (SNSS) , CalciMedica Inc (CALC) have a combined weighting of 12.74% among all his current holdings.

Latest Holdings of Eric Bjerkholt

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MIRM	Mirum Pharmaceuticals Inc	2026-08-11	36,355	98.22	3,570,788
KDNY	Chinook Therapeutics Inc	2023-02-10	38,867	40.39	1,569,838
AIMT	Aimmune Therapeutics Inc	2020-03-12	42,967	34.49	1,481,932
CERS	Cerus Corp	2026-06-09	261,679	2.49	651,581
CORI	Corium International Inc	2016-05-19	24,500	12.68	310,660
SNSS	Sunesis Pharmaceuticals Inc	2015-07-24	637	5.32	3,389
CALC	CalciMedica Inc	2023-05-31	737	1.99	1,467

Holding Weightings of Eric Bjerkholt

Eric Bjerkholt Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Bjerkholt has made a total of 10 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 3 buys and 7 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 6,001 shares on August 11, 2026, which brought Eric Bjerkholt around $599,500.

According to the SEC Form 4 filings, Eric Bjerkholt has made a total of 4 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 857 shares on February 10, 2023, which brought Eric Bjerkholt around $20,354.

According to the SEC Form 4 filings, Eric Bjerkholt has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 1,000 shares on March 12, 2020, which cost Eric Bjerkholt around $15,100.

More details on Eric Bjerkholt's insider transactions can be found in the Insider Trading History of Eric Bjerkholt table.

Insider Trading History of Eric Bjerkholt

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Bjerkholt Trading Performance

GuruFocus tracks the stock performance after each of Eric Bjerkholt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Bjerkholt is 12.14%. GuruFocus also compares Eric Bjerkholt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Bjerkholt within 3 months outperforms 11 times out of 18 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Bjerkholt's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Bjerkholt

Average Return

Average return per transaction

Outperforming Transactions

12 out of 16 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	9.82
Relative Return to S&P 500(%)	8.61

Get the full picture on these stocks

See GF Score, valuation, financials, and warning signs for every stock Eric Bjerkholt owns.

- MIRM - KDNY - AIMT - CERS - CORI - SNSS - CALC

View MIRM Analysis

Eric Bjerkholt Ownership Network

Ownership Network List of Eric Bjerkholt

No Data

Ownership Network Relation of Eric Bjerkholt

Eric Bjerkholt Owned Company Details

What does Aimmune Therapeutics Inc do?

Who are the key executives at Aimmune Therapeutics Inc?

Eric Bjerkholt is the Chief Financial Officer of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Medical Officer Adelman Daniel C Md , and See Remarks Douglas T. Sheehy .

Aimmune Therapeutics Inc (AIMT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aimmune Therapeutics Inc Insider Transactions

No Available Data

What does Cerus Corp do?

Who are the key executives at Cerus Corp?

Eric Bjerkholt is the director of Cerus Corp. Other key executives at Cerus Corp include Chief Legal Officer Chrystal Jensen , Chief Operating Officer Vivek K Jayaraman , and director & President and CEO William Mariner Greenman .

Cerus Corp (CERS) Insider Trades Summary

Over the past 18 months, Eric Bjerkholt made 1 insider transaction in Cerus Corp (CERS) with a net sale of 20,454. Other recent insider transactions involving Cerus Corp (CERS) include a net sale of 367,642 shares made by Vivek K Jayaraman , a net sale of 189,198 shares made by Chrystal Jensen , and a net sale of 821,776 shares made by William Mariner Greenman .

In summary, during the past 3 months, insiders sold 248,949 shares of Cerus Corp (CERS) in total and bought 0 shares, with a net sale of 248,949 shares. During the past 18 months, 2,105,750 shares of Cerus Corp (CERS) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 2,080,750 shares.

Cerus Corp (CERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cerus Corp Insider Transactions

No Available Data

What does CalciMedica Inc do?

Who are the key executives at CalciMedica Inc?

Eric Bjerkholt is the director of CalciMedica Inc. Other key executives at CalciMedica Inc include 10 percent owner Alafi Capital Co Llc , director & 10 percent owner Fred A Middleton , and director & 10 percent owner & Chief Business Officer Eric W Roberts .

CalciMedica Inc (CALC) Insider Trades Summary

Over the past 18 months, Eric Bjerkholt made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 70,927 shares made by Eric W Roberts , a net purchase of 1,000 shares made by Kenneth A. Stauderman , and a net purchase of 15,539 shares made by Sudarshan Hebbar .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 49,794 shares, with a net purchase of 49,794 shares. During the past 18 months, 200 shares of CalciMedica Inc (CALC) were sold and 69,688 shares were bought by its insiders, resulting in a net purchase of 69,488 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

CalciMedica Inc Insider Transactions

No Available Data

What does Corium International Inc do?

Who are the key executives at Corium International Inc?

Eric Bjerkholt is the director of Corium International Inc. Other key executives at Corium International Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .

Corium International Inc (CORI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Corium International Inc (CORI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corium International Inc (CORI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Corium International Inc (CORI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corium International Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Eric Bjerkholt is the EVP & CFO & Corp. Secretary of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Microbot Medical Inc do?

Who are the key executives at Microbot Medical Inc?

Eric Bjerkholt is the director of Microbot Medical Inc. Other key executives at Microbot Medical Inc include Chief Medical Officer Juan Diaz-cartelle , Chief Financial Officer Rachel Vaknin , and General Manager & CTO Simon Sharon .

Microbot Medical Inc (MBOT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Microbot Medical Inc (MBOT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Microbot Medical Inc (MBOT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Microbot Medical Inc (MBOT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Microbot Medical Inc Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Eric Bjerkholt is the Senior VP & CFO of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Financial Officer Michael E. Faerm , Senior VP & Finance Melody Burcar , and Chief Executive Officer Daniel R. Chevallard .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viracta Therapeutics Inc (VIRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Chinook Therapeutics Inc do?

Who are the key executives at Chinook Therapeutics Inc?

Eric Bjerkholt is the Chief Financial Officer of Chinook Therapeutics Inc. Other key executives at Chinook Therapeutics Inc include Head of Renal Discovery Andrew James King , director & President & CEO Eric Dobmeier , and director & 10 percent owner Davis Jerel .

Chinook Therapeutics Inc (KDNY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chinook Therapeutics Inc (KDNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chinook Therapeutics Inc (KDNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chinook Therapeutics Inc (KDNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chinook Therapeutics Inc Insider Transactions

No Available Data

What does Surrozen Inc do?

Who are the key executives at Surrozen Inc?

Eric Bjerkholt is the director of Surrozen Inc. Other key executives at Surrozen Inc include 10 percent owner Chen-ming Yu , 10 percent owner Tcg Crossover Fund Ii, L.p. , and Chief Operating Officer Charles O Williams .

Surrozen Inc (SRZN) Insider Trades Summary

Over the past 18 months, Eric Bjerkholt made no insider transaction in Surrozen Inc (SRZN). Other recent insider transactions involving Surrozen Inc (SRZN) include a net purchase of 1,451,689 shares made by Column Group Iii Gp, Lp , a net purchase of 417,207 shares made by Tim Kutzkey , and a net sale of 125,909 shares made by Tcg Crossover Fund Ii, L.p. .

In summary, during the past 3 months, insiders sold 325,000 shares of Surrozen Inc (SRZN) in total and bought 0 shares, with a net sale of 325,000 shares. During the past 18 months, 335,828 shares of Surrozen Inc (SRZN) were sold and 2,067,987 shares were bought by its insiders, resulting in a net purchase of 1,732,159 shares.

Surrozen Inc (SRZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Surrozen Inc Insider Transactions

No Available Data

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Eric Bjerkholt is the CHIEF FINANCIAL OFFICER of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include SVP & Global Controller Jolanda Howe , director & President and CEO Christopher Peetz , and CHIEF MEDICAL OFFICER Joanne Quan .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Eric Bjerkholt made 7 insider transaction in Mirum Pharmaceuticals Inc (MIRM) with a net sale of 35,340. Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 126,343 shares made by Jolanda Howe , a net sale of 271,301 shares made by Christopher Peetz , and a net sale of 29,180 shares made by Saira Ramasastry .

In summary, during the past 3 months, insiders sold 128,814 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 128,814 shares. During the past 18 months, 680,937 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 131,974 shares were bought by its insiders, resulting in a net sale of 548,963 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

What does Metagenomi Therapeutics Inc do?

Who are the key executives at Metagenomi Therapeutics Inc?

Eric Bjerkholt is the director of Metagenomi Therapeutics Inc. Other key executives at Metagenomi Therapeutics Inc include Chief Financial Officer Pamela Wapnick , director & See Remarks Jian Irish , and See Remarks Matthew Wein .

Metagenomi Therapeutics Inc (MGX) Insider Trades Summary

Over the past 18 months, Eric Bjerkholt made no insider transaction in Metagenomi Therapeutics Inc (MGX). Other recent insider transactions involving Metagenomi Therapeutics Inc (MGX) include a net sale of 11,104 shares made by Pamela Wapnick , a net sale of 1,995 shares made by Matthew Wein , and a net sale of 15,476 shares made by Jian Irish .

In summary, during the past 3 months, insiders sold 4,409 shares of Metagenomi Therapeutics Inc (MGX) in total and bought 20,000 shares, with a net purchase of 15,591 shares. During the past 18 months, 51,130 shares of Metagenomi Therapeutics Inc (MGX) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 31,130 shares.

Metagenomi Therapeutics Inc (MGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metagenomi Therapeutics Inc Insider Transactions

No Available Data

Eric Bjerkholt Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Bjerkholt. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eric Bjerkholt's mailing address is: Kengsington Ca 94708.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.